CCEL vs LLY · P/E 490, rev $31.6M vs P/E 39, rev $22.97B
CryoCell International Inc (CCEL) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Latest reported CCEL revenue for 2025-11-30 was $31.6M. Net income was -$2.4M. CCEL currently screens at market cap $39.6M and trailing P/E 490.0.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the CCEL and LLY stock pages for the full models.
Not investment advice.